Latest Degenerative diseases biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Study Investigates Link Between Sleep Disorders and Alzheimer’s in People With Down Syndrome

by Hospital de la Santa Creu i Sant Pau

1 year ago
Sleep disorders, Down syndrome, Alzheimer

Sleep disorders are highly prevalent among people with Down syndrome, yet they often go undiagnosed. Researchers at the Sant Pau Research Institute (IR Sant Pau) are conducting a pioneering study to e...

IDIVAL Joins the European Joint Action JADE Health to Advance Dementia Prevention and Treatment

by Instituto de Investigación Marqués de Valdecilla

1 year ago
JADE Health

The Valdecilla Health Research Institute (IDIVAL) is participating as an associate entity in the European project JADE Health (Joint Action on Dementia and Health System Sustainability), a joint actio...

Asabys invests in €77.7 million round of Augustine Therapeutics

by Asabys Partners

1 year ago
Augustine Therapeutics, Asabys Partners, cytosolic Histone DeACetylase 6

Augustine Therapeutics, focused on developing new therapies for neuromuscular, neurodegenerative and cardio-metabolic diseases through the inhibition of the cytosolic Histone DeACetylase 6 (HDAC6) enz...

New study compares plasma biomarkers for detecting Alzheimer’s disease in memory clinics

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

1 year ago
phosphorylated tau (p-tau181, p-tau217, p-tau231), total tau (t-tau), amyloid-beta (Aβ42/40), cerebrospinal fluid (CSF), alzheimer

The findings revealed that plasma p-tau biomarkers demonstrated superior accuracy in detecting Alzheimer's compared to other biomarkers, with p-tau217 emerging as the most reliable marker. Notably, p-...

Investigadores del CABD descubren un nuevo mecanismo celular con potencial terapéutico en enfermedades neurodegenerativas

by Universidad Pablo de Olavide, de Sevilla

1 year ago
chaperona EMC, proteína Lam6/Ltc1, ergosterol, ketoconazol, emulsionante tween20 (E432)

Este estudio allana el camino para nuevos enfoques médicos centrados en la modulación de la fluidez de las membranas celulares

Gain Therapeutics announces the administration of its drug GT-02287 to first patient in phase 1b clinical trial for Parkinson’s disease

by Parc Científic de Barcelona

1 year ago
Gain Therapeutics, GT-02287, Parkinson, GBA1 gene, enzyme glucocerebrosidase (GCase), NfL

The clinical-stage biotechnology company, Gain Therapeutics, has announced the administration of the first dose to a participant with Parkinson’s disease in its phase 1b clinical trial of GT-02287, ...

The potential of exosomes in regenerative medicine

by Sermes CRO

1 year ago
exosomes, regenerative medicine

Regenerative medicine has advanced significantly in recent decades, and one of the most promising discoveries in this field is exosomes. These tiny extracellular vesicles are revolutionizing how we un...

A drug used to treat diabetes improves the prognosis of patients undergoing cardiac valve intervention

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

1 year ago
transcatheter aortic valve implantation (TAVI), aortic stenosis, dapagliflozin, SGLT2 inhibitors

The DapaTAVI study, conducted in 39 Spanish hospitals and coordinated by the CNIC, marks a breakthrough in cardiovascular research and could transform the treatment of these patients

Subtle cognitive deficits identified in preclinical stages of Alzheimer’s that could improve early diagnosis and treatment

by Fundació Clínic per a la Recerca Biomèdica

1 year ago
Alzheimer

A study led by IDIBAPS-Hospital Clínic has just detected subtle cognitive deficiencies in people in preclinical stages of the disease, when they are not yet aware of its first symptoms, which could h...

UB researchers develop a new compound with therapeutic potential against Alzheimer’s disease

by Universitat de Barcelona

1 year ago
inhibitor of soluble epoxide hydrolase (sEH), epoxyeicosatrienoic acids (EETs), neuroinflammation, alzheimer

The new compound is an inhibitor of soluble epoxide hydrolase (sEH), an enzyme involved in the regulation of several physiological processes, including inflammation and pain response. In the context o...

Obstructive sleep apnoea worsening inflammation and oxidative damage in Alzheimer's disease patients

by IRB Lleida. Institut de Recerca Biomèdica

1 year ago
Obstructive sleep apnoea, oxidative damage, patients with Alzheimer's disease

Obstructive sleep apnoea worsens inflammation and oxidative damage (the deterioration of cells) in patients with Alzheimer's disease, according to research led by the Cognition and Behaviour Study Gro...

Biotecnología aplicada a la medicina: terapias de precisión

by Asebio

1 year ago
biotecnología, medicina de precisión

La medicina personalizada o de precisión aprovecha los avances biotecnológicos en diversas disciplinas para mejorar el diagnóstico y adaptar las terapias a la singularidad de cada paciente.